We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current LGVN market cap is 25.89M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 121k | 279k | 217k | 150k | 63k |
| Operating Income | -5.24M | -4.72M | -5.71M | -5.16M | -5.44M |
| Net Income | -4.46M | -4.65M | -5.63M | -5.9M | -6.03M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.64M | 5.63M | 1.31M | 1.22M | 709k |
| Operating Income | -3M | -3.78M | -17.46M | -18.04M | -21.03M |
| Net Income | -2.96M | -3.72M | -17.05M | -18.84M | -22.21M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 27.41M | 21.81M | 17.09M | 11.63M | 12.08M |
| Total Liabilities | 6.91M | 5.49M | 5.83M | 4.99M | 5.34M |
| Total Equity | 20.5M | 16.32M | 11.26M | 6.63M | 6.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.58M | 9.24M | 42.77M | 27.41M | 12.08M |
| Total Liabilities | 6.14M | 7.28M | 5.31M | 6.91M | 5.34M |
| Total Equity | 4.45M | 1.96M | 37.45M | 20.5M | 6.74M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.97M | -5.85M | -10.45M | -15.01M | -19M |
| Investing | -677k | 346k | 2.8M | 6.62M | 8.19M |
| Financing | -509k | -17k | -103k | -153k | 5.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.39M | -2.36M | -9.64M | -13.97M | -19M |
| Investing | -125k | -262k | -10.7M | -677k | 8.19M |
| Financing | 350k | 1.58M | 45.16M | -509k | 5.26M |
| Market Cap | 25.89M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 25.13M |
| Average Volume (1 week) | 613.06k |
| Average Volume (1 Month) | 381.7k |
| 52 Week Change | -97.05% |
| 52 Week High | 40.00 |
| 52 Week Low | 1.02 |
| Spread (Intraday) | 0.04 (3.74%) |
| Company Name | Longeveron Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:///www.longeveron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
